These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21465486)

  • 21. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
    Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
    Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X
    J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
    Liu X; Sun SQ; Hassid A; Ostrom RS
    Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
    Yu Z; Xing Y
    Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.
    Bonniaud P; Margetts PJ; Kolb M; Schroeder JA; Kapoun AM; Damm D; Murphy A; Chakravarty S; Dugar S; Higgins L; Protter AA; Gauldie J
    Am J Respir Crit Care Med; 2005 Apr; 171(8):889-98. PubMed ID: 15563636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells.
    Ishikawa F; Nose K; Shibanuma M
    Exp Cell Res; 2008 Jun; 314(10):2131-40. PubMed ID: 18433744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
    Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
    Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-β1 up-regulates connexin43 expression in human granulosa cells.
    Chen YC; Chang HM; Cheng JC; Tsai HD; Wu CH; Leung PC
    Hum Reprod; 2015 Sep; 30(9):2190-201. PubMed ID: 26202915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
    König HG; Kögel D; Rami A; Prehn JH
    J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta 1 increases collagen content, and stimulates procollagen I and tissue inhibitor of metalloproteinase-1 production of dental pulp cells: Role of MEK/ERK and activin receptor-like kinase-5/Smad signaling.
    Lin PS; Chang HH; Yeh CY; Chang MC; Chan CP; Kuo HY; Liu HC; Liao WC; Jeng PY; Yeung SY; Jeng JH
    J Formos Med Assoc; 2017 May; 116(5):351-358. PubMed ID: 27720345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Santander C; Brandan E
    Exp Cell Res; 2010 Sep; 316(15):2487-503. PubMed ID: 20471380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
    J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
    Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
    J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
    Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
    Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
    Chang HH; Chang MC; Wu IH; Huang GF; Huang WL; Wang YL; Lee SY; Yeh CY; Guo MK; Chan CP; Hsien HC; Jeng JH
    J Endod; 2015 Aug; 41(8):1272-80. PubMed ID: 26001858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
    Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
    Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.